Anti-viral therapy for recurrent hepatitis C after living donor liver transplantation

Anti-viral therapy for recurrent hepatitis C after living donor liver transplantation - Anti-viral therapy for hepatitis C after liver transplantation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003286

Enrollment

150

Registered

2010-03-10

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients wiht recurrent hepatitis C after living donor liver transplantation

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Establishment of appropriate treatment strategy for hepatitis C after liver transplantation	—

Countries

Japan

Outcome results